Make In US Campaign: Trump's pharma executive order requires US govt to buy essential drugs from US firms
Washington: US President Donald Trump has signed an executive order directing some federal agencies to prioritize purchasing certain drugs and medical materials when made in the United States.
The scope of the order issued on Thursday (local time) remains unclear, reports CNN, because it will direct the Food and Drug Administration to produce a list of 'essential medicines, medical countermeasures and critical input' that will be covered by the new requirements.
China has been the dominating global player in the production of personal protective equipment (PPE).
And in the United States, 90 percent of all prescriptions are filled by generic drugs and, one in every three pills consumed is produced by an Indian generics manufacturer, according to a study by the Confederation of Indian Industry (CII) and KPMG in April.
And ironically, India gets around 68 percent of its raw materials -- known as active pharmaceutical ingredients (APIs) -- from China.
Also Read: Trump To Sign Orders To Reduce Prescription Drug Prices: Report
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.